SlideShare une entreprise Scribd logo
1  sur  1
Télécharger pour lire hors ligne
0
20
40
60
80
100
120
No Drug Buprenex Only
Number of parvalbumin positive cells
t-Test: Two -Sample Assuming Equal Variances
Buprenex Only No Drug
Mean 98.66666667 58.83333
Variance 227.5833333 30.58333
Observations 3 3
Pooled Variance 129.0833333
Hypothesized Mean Difference 0
df 4
t Stat 4.293952088
P(T<=t) one-tail 0.006353153
t Critical one-tail 2.131846782
P(T<=t) two-tail 0.012706306
t Critical two-tail 2.776445105
83
94
88.5
62
66
64
Dr. William D. Eldred Department of Biology
Examining the Changes in Calcium Binding Protein Expression
Following Blast Induced Brain Injury Using C57BL/6 Mice
Eric Schmidt, Shama Patel
ABSTRACT
EXPERIMENTAL DESIGN
GOALS
We would like to specially thank Gloria DeWalt, Dr. Todd Blute and Dr. William D. Eldred for
their guidance and knowledge throughout our research study. We would also like to thank the
other research students in the Eldred lab that helped us over the summer: Bryan Duong, Biraaj
Mahajan and Sara Mansuri. Funding was generously provided by BU UROP.
Traumatic brain injury (TBI) has been linked to
alterations in calcium homeostasis. TBI can lead to an
influx of calcium ions following injury to the brain that
can be coupled to subsequent cell death through
excitotoxicity.
One of our research goals was to analyze the visual
cortex (V1) and the retrosplenial cortex (RSC) in the
brains of C57BL/6 mice since perturbations in vision and
memory are prevalent symptoms following blast induced
TBI in humans. In order to investigate this goal, a rodent
blast apparatus was used to deliver a nonlethal
overpressure blast to restrained mice in the presence or
absence of the analgesic Buprenex. Following a 48 hour
recovery period, animals were sacrificed, then
immunocytochemistry and confocal microscopy were
utilized to characterize the differences between blasted
mice with and without anesthetics.
The calcium-binding protein parvalbumin was chosen
based on it’s prevalence and ability to identify non-
overlapping neuronal populations in the cortex. Using
antibodies directed against the parvalbumin, we quantified
the number of neuronal cell bodies stained in the cortex.
Our results showed a statistically significant difference
between blasted mice with and without Buprenex. We
conclude that using Buprenex in TBI research may
significantly confound the results.
Figure 1. Cranial
Only Blast Injury
Apparatus (COBIA)
developed by Kuehn
et. al.
In this rodent model, a
nonlethal blast
overpressure is
delivered to the head of
live awake mice using
a 0.22 caliber
smokeless powder
blank cartridge. The
blast is delivered
vertically downwards
directly onto just the
head of the retrained
mouse.
METHODS
Blast Injury Procedure
Our model focuses on blast induced trauma using a Cranial Only Blast
Injury Apparatus (COBIA) developed by Kuehn et al., 2011. The mice
that received Buprenex (0.1mg/kg) were injected at least 10 minutes
prior to blast. A paper cone was used to position the head of mice during
blast. The method and procedures developed adhere to the Guide for
Care and Use of Laboratory Animals.
Tissue Preparation
To prepare the tissue, the mice were anesthetized with isofluorane gas
after a 48 hour survival time and then perfused with fixative and
decapitated. The isolated brain tissue was cryoprotected by placing it in
sucrose solutions of increasing concentrations from 5-30% and left
overnight at 4°C. The tissue was then immersed in embedding media,
frozen, and sliced into 30 μm-thick sections using a microtome. The
tissue was then mounted onto Superfrost/Plus slides for
immunocytochemistry.
Immunocytochemistry
The sections on slides were then sequentially treated with normal
blocking serum, followed by primary and secondary antibodies diluted
in 0.3% Triton X100 and phosphate buffer. The primary antibody was
directed against the calcium binding protein parvalbumin (Novus,
1:5000). The slides were cover slipped with VectaShield.
Image Analysis
The fluorescent labeling was visualized using a Fluoview 10i confocal
microscope. The images were subsequently analyzed using Image J
software to generate inverted images such that signal appeared black on
a white background. The cell counting plugin in Image J was used to
quantify the number of labeled cells.
• To examine the differences in visual cortex and
RSC between sham and blast mice by examining
the calcium binding protein parvalbumin.
• To elucidate the effects of the analgesic Buprenex
anesthetic on TBI.
• To identify which cell signaling pathways are
involved in blast pathology in order to provide a
basis for future research about prevention or
treatment of traumatic brain injuries.
QUANTITATIVE METHODS
FUTURE DIRECTIONS
• In future research, we will carry out similar studies analyzing calcium binding
proteins in the mouse retina and see if significant similarities exist. If so, we may
be able to detect TBI in the brain by analyzing the effects in retina.
• We will do further immunocytochemical studies analyzing other calcium binding
proteins to determine how wide spread the effects are.
• We are also focusing on other brain regions such as the dentate gyrus within the
hippocampus and other corteces.
STATISTICAL RESULTS
CONCLUSIONS
BIBLIOGRAPHY
Figure 2. Parvalbumin
antibody labeling in the
retrosplenial cortex.
Effects of Buprenex on sham and
blasted mice (677, 676, 621,
618). Buprenex decreased the
number of labeled cells in sham
mice and it increased the number
of parvalbumin labeled cells in
the blasted mice.
Figure 3. Statistical
analysis of the effects of
Buprenex on
Parvalbumin levels in
blasted visual cortex.
Results from two different
sections from the same
mouse are shown
vertically. The red
numbers indicate the
number of labeled cells in
each image. The blue
numbers indicate average
number from these two
sections. The statistics are
taken from two different
sections taken from three
different mice.
• Levels of paralbumin are statistically changed in response to blast TBI.
• Buprenex decreases the number of labeled cells in sham mice and it increases the
number of parvalbumin labeled cells in the RSC in blasted mice.
• Buprenex significantly changes the effects of blast in V1 of visual cortex
• The effects of drugs may confound the interpretation of many previous studies of
TBI effects in animal model systems.
Sham Buprenex only Blast Buprenex only
Sham No Drug Blast No Drug
Parvalbumin
Sham no drug Blast no drug
Avg. # of cells 209 cells 87 cells
Average
labeling
intensity
Mean 74
Mean 62
Sham +Bup Blast + Bup
Avg. # of cells 91 cells 139 cells
Average
labeling
intensity
Mean 61
Mean 59
Buprenex Blast No Drug Blast
Reed Kuehn, Philippe F. Simard, Ian Driscoll, Kaspar Keledjian, Svetlana Ivanova, Cigdem
Tosun, Alicia Williams, Grant Bochicchio, Volodymyr Gerzanich, and J. Marc Simard
Rodent Model of Direct Cranial Blast Injury, Journal of Neurotrauma 28:2155–2169
(2011)
Quantification in Image J
ACKNOWLEDGEMENTS

Contenu connexe

Tendances

EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...ChemAxon
 
Epigallocatechin Gallate And Melanoma Chemoprevention
Epigallocatechin Gallate And Melanoma ChemopreventionEpigallocatechin Gallate And Melanoma Chemoprevention
Epigallocatechin Gallate And Melanoma Chemopreventionamandaeverett
 
A disinhibitory microcircuit initiates critical period plasticity in the visu...
A disinhibitory microcircuit initiates critical period plasticity in the visu...A disinhibitory microcircuit initiates critical period plasticity in the visu...
A disinhibitory microcircuit initiates critical period plasticity in the visu...Taruna Ikrar
 
Screening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosisScreening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosisHimanshu Yadav
 
Protein degradation by TRIM-Away, a novel tool learned from innate immunity
Protein degradation by TRIM-Away, a novel tool learned from innate immunityProtein degradation by TRIM-Away, a novel tool learned from innate immunity
Protein degradation by TRIM-Away, a novel tool learned from innate immunityShang Su
 
A miniaturized sandwich immunoassay platform
A miniaturized sandwich immunoassay platformA miniaturized sandwich immunoassay platform
A miniaturized sandwich immunoassay platformQing Chen
 
Immunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistImmunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistDr. Rajesh Bendre
 
Proposal for Protein-DNA Mapping using AFM for Lab on a Chip
Proposal for Protein-DNA Mapping using AFM for Lab on a ChipProposal for Protein-DNA Mapping using AFM for Lab on a Chip
Proposal for Protein-DNA Mapping using AFM for Lab on a ChipAnthony Salvagno
 
Modulation Of Experimental Autoimmune Encephalomyelitis By
Modulation Of Experimental Autoimmune Encephalomyelitis ByModulation Of Experimental Autoimmune Encephalomyelitis By
Modulation Of Experimental Autoimmune Encephalomyelitis ByHoose71
 
poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5Rudy Matheson
 

Tendances (18)

EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
 
Epigallocatechin Gallate And Melanoma Chemoprevention
Epigallocatechin Gallate And Melanoma ChemopreventionEpigallocatechin Gallate And Melanoma Chemoprevention
Epigallocatechin Gallate And Melanoma Chemoprevention
 
Anupom
AnupomAnupom
Anupom
 
A disinhibitory microcircuit initiates critical period plasticity in the visu...
A disinhibitory microcircuit initiates critical period plasticity in the visu...A disinhibitory microcircuit initiates critical period plasticity in the visu...
A disinhibitory microcircuit initiates critical period plasticity in the visu...
 
article2
article2article2
article2
 
Lab report
Lab reportLab report
Lab report
 
Prezentacja wrocław
Prezentacja wrocławPrezentacja wrocław
Prezentacja wrocław
 
Screening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosisScreening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosis
 
Protein degradation by TRIM-Away, a novel tool learned from innate immunity
Protein degradation by TRIM-Away, a novel tool learned from innate immunityProtein degradation by TRIM-Away, a novel tool learned from innate immunity
Protein degradation by TRIM-Away, a novel tool learned from innate immunity
 
Immunoflorescence
ImmunoflorescenceImmunoflorescence
Immunoflorescence
 
Western blotting
Western blottingWestern blotting
Western blotting
 
A miniaturized sandwich immunoassay platform
A miniaturized sandwich immunoassay platformA miniaturized sandwich immunoassay platform
A miniaturized sandwich immunoassay platform
 
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
 
Immunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistImmunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologist
 
Proposal for Protein-DNA Mapping using AFM for Lab on a Chip
Proposal for Protein-DNA Mapping using AFM for Lab on a ChipProposal for Protein-DNA Mapping using AFM for Lab on a Chip
Proposal for Protein-DNA Mapping using AFM for Lab on a Chip
 
Modulation Of Experimental Autoimmune Encephalomyelitis By
Modulation Of Experimental Autoimmune Encephalomyelitis ByModulation Of Experimental Autoimmune Encephalomyelitis By
Modulation Of Experimental Autoimmune Encephalomyelitis By
 
MotM Proposal
MotM ProposalMotM Proposal
MotM Proposal
 
poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5
 

Similaire à EricSchmidtUROPposter2014

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
 
Neurotoxicity assay using High Content Screening technology
Neurotoxicity assay using High Content Screening technologyNeurotoxicity assay using High Content Screening technology
Neurotoxicity assay using High Content Screening technologyHCS Pharma
 
Neurocarrus deck short 7 12-20
Neurocarrus deck short 7 12-20Neurocarrus deck short 7 12-20
Neurocarrus deck short 7 12-20PaulBlum3
 
Lab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisLab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisSantosh Dash
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...HCS Pharma
 
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Arthur Stem
 
Tzekov_PLOSOne_2016 Publication Roskamp.PDF
Tzekov_PLOSOne_2016 Publication Roskamp.PDFTzekov_PLOSOne_2016 Publication Roskamp.PDF
Tzekov_PLOSOne_2016 Publication Roskamp.PDFMegan Orlando
 
Phenotypic screening using MEAs
Phenotypic screening using MEAsPhenotypic screening using MEAs
Phenotypic screening using MEAsNeuroProof GmbH
 
TBI Presentation 02 Updated.pptx
TBI Presentation 02 Updated.pptxTBI Presentation 02 Updated.pptx
TBI Presentation 02 Updated.pptxXiaomiRedmi22
 
Poster Presentation
Poster PresentationPoster Presentation
Poster PresentationChunghee Kim
 
140514 - HD synaptic characterization
140514 - HD synaptic characterization140514 - HD synaptic characterization
140514 - HD synaptic characterizationAJ Keefe
 

Similaire à EricSchmidtUROPposter2014 (20)

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
Neurotoxicity assay using High Content Screening technology
Neurotoxicity assay using High Content Screening technologyNeurotoxicity assay using High Content Screening technology
Neurotoxicity assay using High Content Screening technology
 
Neurocarrus deck short 7 12-20
Neurocarrus deck short 7 12-20Neurocarrus deck short 7 12-20
Neurocarrus deck short 7 12-20
 
Karla UROP poster
Karla UROP poster Karla UROP poster
Karla UROP poster
 
Lab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisLab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune Encephalitis
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
 
uantitative Morphometric Analysis of Immunochemistry Images of the Spinal Dor...
uantitative Morphometric Analysis of Immunochemistry Images of the Spinal Dor...uantitative Morphometric Analysis of Immunochemistry Images of the Spinal Dor...
uantitative Morphometric Analysis of Immunochemistry Images of the Spinal Dor...
 
Articulo electro y celulas
Articulo  electro y celulasArticulo  electro y celulas
Articulo electro y celulas
 
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
 
Tzekov_PLOSOne_2016 Publication Roskamp.PDF
Tzekov_PLOSOne_2016 Publication Roskamp.PDFTzekov_PLOSOne_2016 Publication Roskamp.PDF
Tzekov_PLOSOne_2016 Publication Roskamp.PDF
 
Phenotypic screening using MEAs
Phenotypic screening using MEAsPhenotypic screening using MEAs
Phenotypic screening using MEAs
 
Gellibolian 2010 Audio Visual2
Gellibolian 2010 Audio Visual2Gellibolian 2010 Audio Visual2
Gellibolian 2010 Audio Visual2
 
TBI Presentation 02 Updated.pptx
TBI Presentation 02 Updated.pptxTBI Presentation 02 Updated.pptx
TBI Presentation 02 Updated.pptx
 
fnsys-09-00015
fnsys-09-00015fnsys-09-00015
fnsys-09-00015
 
fnsys-09-00015
fnsys-09-00015fnsys-09-00015
fnsys-09-00015
 
synapse microarray ppt
synapse microarray pptsynapse microarray ppt
synapse microarray ppt
 
Poster Presentation
Poster PresentationPoster Presentation
Poster Presentation
 
140514 - HD synaptic characterization
140514 - HD synaptic characterization140514 - HD synaptic characterization
140514 - HD synaptic characterization
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Diapos seminario microglía
Diapos seminario microglía Diapos seminario microglía
Diapos seminario microglía
 

EricSchmidtUROPposter2014

  • 1. 0 20 40 60 80 100 120 No Drug Buprenex Only Number of parvalbumin positive cells t-Test: Two -Sample Assuming Equal Variances Buprenex Only No Drug Mean 98.66666667 58.83333 Variance 227.5833333 30.58333 Observations 3 3 Pooled Variance 129.0833333 Hypothesized Mean Difference 0 df 4 t Stat 4.293952088 P(T<=t) one-tail 0.006353153 t Critical one-tail 2.131846782 P(T<=t) two-tail 0.012706306 t Critical two-tail 2.776445105 83 94 88.5 62 66 64 Dr. William D. Eldred Department of Biology Examining the Changes in Calcium Binding Protein Expression Following Blast Induced Brain Injury Using C57BL/6 Mice Eric Schmidt, Shama Patel ABSTRACT EXPERIMENTAL DESIGN GOALS We would like to specially thank Gloria DeWalt, Dr. Todd Blute and Dr. William D. Eldred for their guidance and knowledge throughout our research study. We would also like to thank the other research students in the Eldred lab that helped us over the summer: Bryan Duong, Biraaj Mahajan and Sara Mansuri. Funding was generously provided by BU UROP. Traumatic brain injury (TBI) has been linked to alterations in calcium homeostasis. TBI can lead to an influx of calcium ions following injury to the brain that can be coupled to subsequent cell death through excitotoxicity. One of our research goals was to analyze the visual cortex (V1) and the retrosplenial cortex (RSC) in the brains of C57BL/6 mice since perturbations in vision and memory are prevalent symptoms following blast induced TBI in humans. In order to investigate this goal, a rodent blast apparatus was used to deliver a nonlethal overpressure blast to restrained mice in the presence or absence of the analgesic Buprenex. Following a 48 hour recovery period, animals were sacrificed, then immunocytochemistry and confocal microscopy were utilized to characterize the differences between blasted mice with and without anesthetics. The calcium-binding protein parvalbumin was chosen based on it’s prevalence and ability to identify non- overlapping neuronal populations in the cortex. Using antibodies directed against the parvalbumin, we quantified the number of neuronal cell bodies stained in the cortex. Our results showed a statistically significant difference between blasted mice with and without Buprenex. We conclude that using Buprenex in TBI research may significantly confound the results. Figure 1. Cranial Only Blast Injury Apparatus (COBIA) developed by Kuehn et. al. In this rodent model, a nonlethal blast overpressure is delivered to the head of live awake mice using a 0.22 caliber smokeless powder blank cartridge. The blast is delivered vertically downwards directly onto just the head of the retrained mouse. METHODS Blast Injury Procedure Our model focuses on blast induced trauma using a Cranial Only Blast Injury Apparatus (COBIA) developed by Kuehn et al., 2011. The mice that received Buprenex (0.1mg/kg) were injected at least 10 minutes prior to blast. A paper cone was used to position the head of mice during blast. The method and procedures developed adhere to the Guide for Care and Use of Laboratory Animals. Tissue Preparation To prepare the tissue, the mice were anesthetized with isofluorane gas after a 48 hour survival time and then perfused with fixative and decapitated. The isolated brain tissue was cryoprotected by placing it in sucrose solutions of increasing concentrations from 5-30% and left overnight at 4°C. The tissue was then immersed in embedding media, frozen, and sliced into 30 μm-thick sections using a microtome. The tissue was then mounted onto Superfrost/Plus slides for immunocytochemistry. Immunocytochemistry The sections on slides were then sequentially treated with normal blocking serum, followed by primary and secondary antibodies diluted in 0.3% Triton X100 and phosphate buffer. The primary antibody was directed against the calcium binding protein parvalbumin (Novus, 1:5000). The slides were cover slipped with VectaShield. Image Analysis The fluorescent labeling was visualized using a Fluoview 10i confocal microscope. The images were subsequently analyzed using Image J software to generate inverted images such that signal appeared black on a white background. The cell counting plugin in Image J was used to quantify the number of labeled cells. • To examine the differences in visual cortex and RSC between sham and blast mice by examining the calcium binding protein parvalbumin. • To elucidate the effects of the analgesic Buprenex anesthetic on TBI. • To identify which cell signaling pathways are involved in blast pathology in order to provide a basis for future research about prevention or treatment of traumatic brain injuries. QUANTITATIVE METHODS FUTURE DIRECTIONS • In future research, we will carry out similar studies analyzing calcium binding proteins in the mouse retina and see if significant similarities exist. If so, we may be able to detect TBI in the brain by analyzing the effects in retina. • We will do further immunocytochemical studies analyzing other calcium binding proteins to determine how wide spread the effects are. • We are also focusing on other brain regions such as the dentate gyrus within the hippocampus and other corteces. STATISTICAL RESULTS CONCLUSIONS BIBLIOGRAPHY Figure 2. Parvalbumin antibody labeling in the retrosplenial cortex. Effects of Buprenex on sham and blasted mice (677, 676, 621, 618). Buprenex decreased the number of labeled cells in sham mice and it increased the number of parvalbumin labeled cells in the blasted mice. Figure 3. Statistical analysis of the effects of Buprenex on Parvalbumin levels in blasted visual cortex. Results from two different sections from the same mouse are shown vertically. The red numbers indicate the number of labeled cells in each image. The blue numbers indicate average number from these two sections. The statistics are taken from two different sections taken from three different mice. • Levels of paralbumin are statistically changed in response to blast TBI. • Buprenex decreases the number of labeled cells in sham mice and it increases the number of parvalbumin labeled cells in the RSC in blasted mice. • Buprenex significantly changes the effects of blast in V1 of visual cortex • The effects of drugs may confound the interpretation of many previous studies of TBI effects in animal model systems. Sham Buprenex only Blast Buprenex only Sham No Drug Blast No Drug Parvalbumin Sham no drug Blast no drug Avg. # of cells 209 cells 87 cells Average labeling intensity Mean 74 Mean 62 Sham +Bup Blast + Bup Avg. # of cells 91 cells 139 cells Average labeling intensity Mean 61 Mean 59 Buprenex Blast No Drug Blast Reed Kuehn, Philippe F. Simard, Ian Driscoll, Kaspar Keledjian, Svetlana Ivanova, Cigdem Tosun, Alicia Williams, Grant Bochicchio, Volodymyr Gerzanich, and J. Marc Simard Rodent Model of Direct Cranial Blast Injury, Journal of Neurotrauma 28:2155–2169 (2011) Quantification in Image J ACKNOWLEDGEMENTS